This is not the most recent version of the article. View current version (31 MAY 2013)

Intervention Protocol

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

  1. Luit Penninga1,*,
  2. Elisabeth I Penninga2,
  3. Christian H Møller3,
  4. Daniel A Steinbrüchel4,
  5. Christian Gluud5

Editorial Group: Cochrane Renal Group

Published Online: 10 NOV 2010

Assessed as up-to-date: 25 SEP 2010

DOI: 10.1002/14651858.CD008817


How to Cite

Penninga L, Penninga EI, Møller CH, Steinbrüchel DA, Gluud C. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 11. Art. No.: CD008817. DOI: 10.1002/14651858.CD008817.

Author Information

  1. 1

    Rigshospitalet, Copenhagen University Hospital, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Dept 3344 & Surgery and Transplantation, Dept C2122, Copenhagen, Denmark

  2. 2

    Bispebjerg Hospital, Department of Clinical Pharmacology, Copenhagen, Denmark

  3. 3

    Copenhagen University Hospital, Dept 2152, Copenhagen Trial Unit, Copenhagen, Denmark

  4. 4

    Rigshospitalet, Copenhagen University Hospital, Dept 2152, Cardiothoracic Surgery, Copenhagen, Denmark

  5. 5

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Luit Penninga, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Dept 3344 & Surgery and Transplantation, Dept C2122, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. LP@ctu.rh.dk. luitpenninga@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 10 NOV 2010

SEARCH

This is not the most recent version of the article. View current version (31 MAY 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review aims to look at the benefits and harms of tacrolimus versus cyclosporin for immunosuppressive treatment in lung transplantation.